Printer Friendly
The Free Library
14,503,922 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Medinet to Participate in Establishment of Tokyo Bay Medical Frontier.


Tokyo, Japan, June 15, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Medinet announced plans o June 14 to participate in the establishment of the Tokyo Bay Medical Frontier (TBMF TBMF Triangle Beach Music Festival (Garner, NC)
TBMF Temperate Broadleaf and Mixed Forests
).

Promoted by NPO NPO [L.] nil per os (nothing by mouth).

NPO
abbr.
Latin nil per os (nothing by mouth)


NPO Nothing by mouth
 Tokyo Enterprise of Advanced Medical Network (TeamNET), the TBMF aims to set up a regional network and shared facility for cancer treatment. As an initial step, the TBMF proceeds with a plan of establishing the Tokyo Bay Medical Frontier Center, a shared facility that will provide the cutting-edge cancer treatments such as heavy particle therapy and immune cell therapy.

The center is scheduled to go into operation by 2010. The TBMF plans to draw a project plan and complete a feasibility study "A Feasibility Study" is an episode of the original The Outer Limits television show. It first aired on 13 April, 1964, during the first season. It was remade in 1997 as part of the revived The Outer Limits series with a minor title change.  a year from now.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jun 16, 2006
Words:123
Previous Article:Ono Pharmaceutical, Banyu Pharmaceutical Jointly Confirm Hypoglycemic Effect of DPP4 Inhibitor Sitagliptin.
Next Article:Nisshin Science Confirms that Renacare Carnitine Jelly Improves Anemia Associated with Diabetic Nephropathy.



Related Articles
Yokohama Rubber Ltd.(Acquisitions, Expansions)
Medinet to Support University of Tokyo Hospital's 22nd Century Medical Center Project for Immune Cell Therapy.
Medinet, Two Medical Institutions Jointly Launch Clinical Studies of Gamma-delta T Cell Therapy for Multiple Myeloma.
Medinet, University of Tokyo Hospital Jointly Undertake Animal Experiments for Immune Cell Therapy.
Honda to Strengthen Racing Circuit Operations.
MEDINET, Yokohama City University, Shin-Yokohama Medical Clinic Jointly Launch Clinical Study of Immune Cell Therapy for Pancreatic Cancer.
Medinet, University of Tokyo, Shin-Yokohama Medical Clinic Jointly Launch Clinical Studies of Activated Self Gamma-delta T Cell Therapy for Non-Small...
Astellas Establishes New Subsidiary 'Astellas Pharma Chemicals Co., Ltd.'.
Shares in Showa Aluminum Powder to be Transferred to the ITOCHU Group.
NEC, Medical Information Service to Provide Maintenance Service for Medical Information Systems.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles